Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02581215
Title Phase II Randomized Trial of FOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Walid Shaib, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic-Arizona Scottsdale Arizona 85259 United States Details
Emory University: Winship Cancer Institute Atlanta Georgia 30322 United States Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Community Healthcare System Munster Indiana 46321 United States Details
University of Louisville, James Graham Brown Cancer Center Louisville Kentucky 40202 United States Details
Nebraska Methodist Hospital Omaha Nebraska 68114 United States Details
Gettysburg Cancer Center Gettysburg Pennsylvania 17325 United States Details
Thomas Jefferson University Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field